251 related articles for article (PubMed ID: 30778902)
41. Comparative proteomic analysis of ductal and lobular invasive breast carcinoma.
Oliveira NC; Gomig TH; Milioli HH; Cordeiro F; Costa GG; Urban CA; Lima RS; Cavalli IJ; Ribeiro EM
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173185
[TBL] [Abstract][Full Text] [Related]
42. Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients.
Laurberg T; Alsner J; Tramm T; Jensen V; Lyngholm CD; Christiansen PM; Overgaard J
Acta Oncol; 2017 Jan; 56(1):59-67. PubMed ID: 27846764
[TBL] [Abstract][Full Text] [Related]
43. Clinical characteristics and survival analysis of breast cancer molecular subtypes with hepatic metastases.
Ge QD; Lv N; Kong YN; Xie XH; He N; Xie XM; Wei WD
Asian Pac J Cancer Prev; 2012; 13(10):5081-6. PubMed ID: 23244114
[TBL] [Abstract][Full Text] [Related]
44. [Expression of CD44 variant v6 in breast carcinoma and its relationship with other parameters of tumor biology].
Aceituno E; Turrión F; San Román JM; Sarasa JL; Ortiz F; García R
Med Clin (Barc); 1998 Jul; 111(5):168-71. PubMed ID: 9732832
[TBL] [Abstract][Full Text] [Related]
45. Comparative expressed sequence hybridization reveals differential gene expression in morphological breast cancer subtypes.
Vanden Bempt I; Vanhentenrijk V; Drijkoningen M; De Wolf-Peeters C
J Pathol; 2006 Mar; 208(4):486-94. PubMed ID: 16402338
[TBL] [Abstract][Full Text] [Related]
46. Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast.
Yoder BJ; Wilkinson EJ; Massoll NA
Breast J; 2007; 13(2):172-9. PubMed ID: 17319859
[TBL] [Abstract][Full Text] [Related]
47. Gene Expression Analysis Identifies Common and Distinct Signatures Underlying Ductal and Lobular Breast Cancers.
Huang Q; Liu J; Chen T; Li L; Wang L; Wu Y
J Reprod Med; 2017; 62(5-6):271-83. PubMed ID: 30027719
[TBL] [Abstract][Full Text] [Related]
48. Distribution of CD44/CD24 positive cells in ductal invasive carcinoma of breast of different grade and molecular subtype.
Gudadze M; Kankava K; Mariamidze A; Mosidze T; Burkadze G
Georgian Med News; 2013 Sep; (222):50-7. PubMed ID: 24099815
[TBL] [Abstract][Full Text] [Related]
49. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.
Han W; Jung EM; Cho J; Lee JW; Hwang KT; Yang SJ; Kang JJ; Bae JY; Jeon YK; Park IA; Nicolau M; Jeffrey SS; Noh DY
Genes Chromosomes Cancer; 2008 Jun; 47(6):490-9. PubMed ID: 18314908
[TBL] [Abstract][Full Text] [Related]
50. Breast cancer subtypes identified by the ER, PR and HER-2 status in Thai women.
Chuthapisith S; Permsapaya W; Warnnissorn M; Akewanlop C; Sirivatanauksorn V; Prasarttong Osoth P
Asian Pac J Cancer Prev; 2012; 13(2):459-62. PubMed ID: 22524806
[TBL] [Abstract][Full Text] [Related]
51. Expression of human endogenous retrovirus-K is strongly associated with the basal-like breast cancer phenotype.
Johanning GL; Malouf GG; Zheng X; Esteva FJ; Weinstein JN; Wang-Johanning F; Su X
Sci Rep; 2017 Feb; 7():41960. PubMed ID: 28165048
[TBL] [Abstract][Full Text] [Related]
52. Large-scale analysis of
Croes L; Beyens M; Fransen E; Ibrahim J; Vanden Berghe W; Suls A; Peeters M; Pauwels P; Van Camp G; Op de Beeck K
Clin Epigenetics; 2018; 10():51. PubMed ID: 29682089
[TBL] [Abstract][Full Text] [Related]
53. Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics.
McCart Reed AE; Kutasovic JR; Lakhani SR; Simpson PT
Breast Cancer Res; 2015 Jan; 17(1):12. PubMed ID: 25849106
[TBL] [Abstract][Full Text] [Related]
54. STK3 higher expression association with clinical characteristics in intrinsic subtypes of breast cancer invasive ductal carcinoma patients.
Rukhsana ; Supty AT; Hussain M; Lee Y
Breast Cancer Res Treat; 2024 Jul; 206(1):119-129. PubMed ID: 38592540
[TBL] [Abstract][Full Text] [Related]
55. Tumor intrinsic subtype is reflected in cancer-adjacent tissue.
Casbas-Hernandez P; Sun X; Roman-Perez E; D'Arcy M; Sandhu R; Hishida A; McNaughton KK; Yang XR; Makowski L; Sherman ME; Figueroa JD; Troester MA
Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):406-14. PubMed ID: 25465802
[TBL] [Abstract][Full Text] [Related]
56. Nm-23, c-erbB-2, and progesterone receptor expression in invasive breast cancer: correlation with clinicopathologic parameters.
Nakopoulou LL; Tsitsimelis D; Lazaris AC; Tzonou A; Gakiopoulou H; Dicoglou CC; Davaris PS
Cancer Detect Prev; 1999; 23(4):297-308. PubMed ID: 10403901
[TBL] [Abstract][Full Text] [Related]
57. HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial.
Llombart-Cussac A; Cortés J; Paré L; Galván P; Bermejo B; Martínez N; Vidal M; Pernas S; López R; Muñoz M; Nuciforo P; Morales S; Oliveira M; de la Peña L; Peláez A; Prat A
Lancet Oncol; 2017 Apr; 18(4):545-554. PubMed ID: 28238593
[TBL] [Abstract][Full Text] [Related]
58. Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature.
Mook S; Knauer M; Bueno-de-Mesquita JM; Retel VP; Wesseling J; Linn SC; Van't Veer LJ; Rutgers EJ
Ann Surg Oncol; 2010 May; 17(5):1406-13. PubMed ID: 20094918
[TBL] [Abstract][Full Text] [Related]
59. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
Yie SM; Luo B; Ye NY; Xie K; Ye SR
Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
[TBL] [Abstract][Full Text] [Related]
60. Differential loss of heterozygosity profile on chromosome 3p in ductal and lobular breast carcinomas.
de Oliveira MM; de Oliveira SF; Lima RS; de Andrade Urban C; Cavalli LR; de Souza Fonseca Ribeiro EM; Cavalli IJ
Hum Pathol; 2012 Oct; 43(10):1661-7. PubMed ID: 22503535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
